US Patent Issued to ESSENTIALIS on July 1 for "Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome" (California Inventor)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,348, issued on July 1, was assigned to ESSENTIALIS INC. (Redwood City, Calif.).

"Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome" was invented by Neil M. Cowen (Carlsbad, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are immediate or prolonged administration of certain potassium ATP (KATP) channel openers, optionally in combination with growth hormone, to a subject to achieve novel pharmacodynamic, pharmacokinetic, therapeutic, physiological, metabolic and compositional outcomes in the treatment of diseases or conditions involving KATP channels. Also provided are pharmaceutical formulations, methods...